Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.

Bio-Path Holdings unveils preclinical success for BP1001-A in treating obesity and Type 2 diabetes

Pallavi Madhiraju- December 19, 2024 0

Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology innovator known for leveraging its DNAbilize liposomal delivery platform, has announced promising preclinical study results for BP1001-A, a ... Read More

Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies

Pallavi Madhiraju- December 18, 2024 0

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage pharmaceutical company focused on neurodegenerative disorder treatment, has reported highly encouraging Phase 2 trial results for CT1812, a ... Read More

Polyrizon prepares for allergy blocker trial with strategic manufacturing partnership

Pallavi Madhiraju- December 18, 2024 0

Polyrizon Ltd., a biotech company known for its cutting-edge nasal hydrogel technology, has solidified its preparations for the anticipated 2025 allergy blocker trial by entering ... Read More

Corvus Pharmaceuticals shares surge ahead of Phase 1 data release for Soquelitinib

Pallavi Madhiraju- December 18, 2024 0

Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company, is poised to announce interim results from its Phase 1 trial evaluating soquelitinib as a potential treatment for moderate ... Read More

Tenaya Therapeutics’ TN-201 demonstrates tolerability and protein expression in early HCM trial

Pallavi Madhiraju- December 17, 2024 0

Tenaya Therapeutics, a clinical-stage biotechnology company, has released promising interim results from its MyPEAK-1 Phase 1b/2 clinical trial evaluating TN-201 gene therapy for MYBPC3-associated hypertrophic ... Read More

Portage Biotech and Immunova sign LOI for potential iOx Therapeutics acquisition

Pallavi Madhiraju- December 17, 2024 0

Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing innovative therapies to target cancer, has entered into a Letter of Intent (LOI) with Immunova, ... Read More

FDA acceptance propels Tonix Pharmaceuticals’ TNX-102 SL towards fibromyalgia treatment approval

Pallavi Madhiraju- December 17, 2024 0

Tonix Pharmaceuticals Holding Corp. has achieved a pivotal milestone with the FDA acceptance announcement for its New Drug Application (NDA) of TNX-102 SL, a novel ... Read More

Supriya Lifescience boosts API capacity with Rs 125cr Module E facility

Pallavi Madhiraju- December 17, 2024 0

Supriya Lifescience Ltd, a leading player in the pharmaceutical industry growth segment, has unveiled its latest Module E production block at its cutting-edge facility in ... Read More

Three biosimilars by Celltrion near EU approval following CHMP endorsement

Pallavi Madhiraju- December 16, 2024 0

Celltrion, a leading South Korean biopharmaceutical company, has received positive opinions from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ... Read More

Gilead Sciences’ seladelpar gains support as PBC treatment in Europe

Pallavi Madhiraju- December 15, 2024 0

In a significant milestone for liver disease therapeutics, Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the ... Read More